Based on stakeholder feedback received in May 2015, CADTH has announced that in the limited instances where no Canadian patient ... Read More
Events
06
Oct2015
30
Sep2015
Report 4: PLA Perspectives, Comparison and Contrast
Last week Manulife introduced its new DrugWatch™. It has been described by Manulife ... Read More
17
Sep2015
Report 3: Experience Negotiating Private Payer PLAs
PDCI Market Access (PDCI) and H3 Consulting (H3) recently launched the Private Payer Product ... Read More
09
Sep2015
Report 2: Negotiation-Naïve & Interested in Negotiating a Private Payer PLA
PDCI Market Access (PDCI) and H3 Consulting (H3) recently launched ... Read More
03
Sep2015
Report 1: Negotiation-Naïve & No Interest in Negotiating a Private Payer PLA
PDCI Market Access (PDCI) and H3 Consulting (H3) conducted ... Read More
31
Jul2015
Topics covered in the NEWSletter include:
Soliris Pre-Hearing Conference
New Staff Member – Legal Services
Update: Compendium of Policies, Guidelines and Procedures
Part C ... Read More
27
Jul2015
Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and ... Read More
20
Jul2015
PDCI & H3 Survey on Private Payer Product Listing Agreements Now “Closed” for Responses
As noted in the June 24th TargetPharma, ... Read More